These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28157063)

  • 21. The potentially harmful excipients in prescribed medications in a Neonatal Intensive Care Unit in Kosovo and available safer alternatives.
    Koshi B; Grapci AD; Nebija D; Selmani PB; Morina R; Crcarevska MS; Dodov MG; Raichki RS
    Turk J Pediatr; 2022; 64(1):49-58. PubMed ID: 35286030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates.
    Kulo A; de Hoon JN; Allegaert K
    Int J Pharm; 2012 Oct; 435(2):112-4. PubMed ID: 22641171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of propylene glycol after rectal administration.
    Kollöffel WJ; Weekers LE; Goldhoorn PB
    Pharm World Sci; 1996 Jun; 18(3):109-13. PubMed ID: 8826536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excipients in Neonatal Medicinal Products: Never Prescribed, Commonly Administered.
    Valeur KS; Holst H; Allegaert K
    Pharmaceut Med; 2018; 32(4):251-258. PubMed ID: 30174435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excipients in medicinal products used in gastroenterology as a possible cause of side effects.
    Ursino MG; Poluzzi E; Caramella C; De Ponti F
    Regul Toxicol Pharmacol; 2011 Jun; 60(1):93-105. PubMed ID: 21354240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated intake of intense sweeteners from non-alcoholic beverages in Denmark.
    Leth T; Fabricius N; Fagt S
    Food Addit Contam; 2007 Mar; 24(3):227-35. PubMed ID: 17364923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety issues with ethanol as an excipient in drugs intended for pediatric use.
    Zuccotti GV; Fabiano V
    Expert Opin Drug Saf; 2011 Jul; 10(4):499-502. PubMed ID: 21417862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low but inducible contribution of renal elimination to clearance of propylene glycol in preterm and term neonates.
    De Cock RF; Allegaert K; Vanhaesebrouck S; de Hoon J; Verbesselt R; Danhof M; Knibbe CA
    Ther Drug Monit; 2014 Jun; 36(3):278-87. PubMed ID: 24305628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.
    Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ
    Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceutical Excipient Exposure in a Neonatal Intensive Care Unit.
    Nasrollahi S; Meera NK; Boregowda S
    Indian Pediatr; 2020 Sep; 57(9):801-804. PubMed ID: 32999107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical excipients. Adverse effects associated with inactive ingredients in drug products (Part I).
    Golightly LK; Smolinske SS; Bennett ML; Sutherland EW; Rumack BH
    Med Toxicol Adverse Drug Exp; 1988; 3(2):128-65. PubMed ID: 3287089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethanol pharmacokinetics in neonates and infants.
    Marek E; Kraft WK
    Curr Ther Res Clin Exp; 2014 Dec; 76():90-7. PubMed ID: 25379066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates.
    Mulla H; Yakkundi S; McElnay J; Lutsar I; Metsvaht T; Varendi H; Nellis G; Nunn A; Duncan J; Pandya H; Turner M
    Pharm Res; 2015 Mar; 32(3):1084-93. PubMed ID: 25236342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal Formulations: The Need for a Tailored, Knowledge Driven Approach.
    Allegaert K; Cosaert K; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5674-9. PubMed ID: 26323412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential confounding effects of benzyl alcohol as a formulation excipient support the elimination of the abnormal toxicity test from pharmacopoeias.
    Xie J; Ottaviani G; Sun K; Lu M; Wu X; Huang S; Bopst M
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):509-14. PubMed ID: 26449397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of formulation excipients on human intestinal transit.
    Schulze JD; Ashiru DA; Khela MK; Evans DF; Patel R; Parsons GE; Coffin MD; Basit AW
    J Pharm Pharmacol; 2006 Jun; 58(6):821-5. PubMed ID: 16734983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anesthetic management of a patient with an allergy to propylene glycol and parabens.
    Farber MK; Angelo TE; Castells M; Tsen LC
    Anesth Analg; 2010 Mar; 110(3):839-42. PubMed ID: 20185660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version.
    Salunke S; Brandys B; Giacoia G; Tuleu C
    Int J Pharm; 2013 Nov; 457(1):310-22. PubMed ID: 24070789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug delivery and formulations.
    Breitkreutz J; Boos J
    Handb Exp Pharmacol; 2011; 205():91-107. PubMed ID: 21882107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimated intake of intense sweeteners from non-alcoholic beverages in Denmark, 2005.
    Leth T; Jensen U; Fagt S; Andersen R
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2008 Jun; 25(6):662-8. PubMed ID: 18484294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.